NCT03849287

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

An Open-label, Randomized, Fasted, Single-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Between Administration of CKD-333 and Coadministration of CKD-330 and D090 in Healthy Male Adults

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The object of clinical trial is to investigate the pharmacokinetics and safety compared to CKD-333 and co-administration CKD-330, D090 under fasting condition in healthy male adults.

Detailed description

An open-label, randomized, fasted, single-dose, three-way crossover study to compare the pharmacokinetic characteristics and safety between administration of CKD-333 and coadministration of CKD-330 and D090 in healthy male adults

Conditions

• Hypertension
• Dyslipidemias

Interventions

Type	Name	Description
DRUG	CKD-333, formula I	Test drug
DRUG	CKD-333, formula II	Test drug
DRUG	CKD-330, D090	Reference Drug

Timeline

• Start date: 2019-02-25
• Primary completion: 2019-03-29
• Completion: 2019-04-06
• First posted: 2019-02-21
• Last updated: 2019-02-22

Locations

1 site across 1 country: South Korea